Clínic Barcelona

New strategies to improve the efficacy of CAR T-cell therapy in solid tumours

A study led by researchers from the Clínic-IDIBAPS paves the way for the design and optimization of CAR T-cell therapy for greater effectiveness in the treatment of solid tumours. More specifically, it demonstrates how the affinity of the CAR T-cell to the tumour receptor modulates both its efficacy and resistance to the suppressive mechanisms of solid tumours.  

From left ro right: Alba Rodríguez-García, Irene Andreu-Saumell and Sonia Guedan

Keep reading about:

Related news